Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
88,059,438
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
11,151,290
-
Shares change
-
-544,951
-
Total reported value, excl. options
-
$83,635,000
-
Value change
-
-$5,010,818
-
Number of buys
-
12
-
Number of sells
-
-13
-
Price
-
$7.5
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q4 2019
34 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q4 2019.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,151,290 shares
of 88,059,438 outstanding shares and own 12.66% of the company stock.
Largest 10 shareholders include 5AM Venture Management, LLC (3,463,066 shares), Canaan Partners X LLC (2,660,713 shares), BVF INC/IL (1,436,429 shares), PERCEPTIVE ADVISORS LLC (1,141,484 shares), BOXER CAPITAL, LLC (764,252 shares), Alphabet Inc. (753,187 shares), BAKER BROS. ADVISORS LP (200,000 shares), Point72 Asset Management, L.P. (197,615 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (174,083 shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (85,000 shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.